IL-4 Induced Innate CD8 T Cells Control Persistent Viral Infection
Over the course of viral infection there may be a limited time period during which the host system can eliminate the virus. When viruses are not eliminated within this period of time, virus can establish persistent infection. Here, we show that IL-4-induced innate CD8+ T cells are able to effectively control chronic virus infection. Innate T cells are heterogeneous population of T cells that acquire effector/memory phenotype as a result of their maturation process in thymus, unlike conventional T cells that differentiate into memory cells after antigen encounter in periphery. Previous data suggest that innate T cells might serve as a first-line of defense against certain bacterial pathogens. IL-4-induced innate CD8+ T cells are a unique subset of innate T cells that were recently identified in both mouse and human. We found that IL-4-induced innate CD8+ T cells immediately accumulated after viral infection and produced a robust amount of effector cytokines. Thereby, IL-4-induced innate CD8+ T cells provide an effective barrier to the establishment of persistent infection via effective virus control during the early phase of viral infection. Collectively our data show that IL-4-induced innate CD8+ T cells works as an early defense mechanism against chronic viral infection.
Vyšlo v časopise:
IL-4 Induced Innate CD8 T Cells Control Persistent Viral Infection. PLoS Pathog 11(10): e32767. doi:10.1371/journal.ppat.1005193
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1005193
Souhrn
Over the course of viral infection there may be a limited time period during which the host system can eliminate the virus. When viruses are not eliminated within this period of time, virus can establish persistent infection. Here, we show that IL-4-induced innate CD8+ T cells are able to effectively control chronic virus infection. Innate T cells are heterogeneous population of T cells that acquire effector/memory phenotype as a result of their maturation process in thymus, unlike conventional T cells that differentiate into memory cells after antigen encounter in periphery. Previous data suggest that innate T cells might serve as a first-line of defense against certain bacterial pathogens. IL-4-induced innate CD8+ T cells are a unique subset of innate T cells that were recently identified in both mouse and human. We found that IL-4-induced innate CD8+ T cells immediately accumulated after viral infection and produced a robust amount of effector cytokines. Thereby, IL-4-induced innate CD8+ T cells provide an effective barrier to the establishment of persistent infection via effective virus control during the early phase of viral infection. Collectively our data show that IL-4-induced innate CD8+ T cells works as an early defense mechanism against chronic viral infection.
Zdroje
1. Berg LJ (2007) Signalling through TEC kinases regulates conventional versus innate CD8+ T-cell development. Nat Rev Immunol 7: 479–485. 17479128
2. Veillette A, Dong Z, Latour S (2007) Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 27: 698–710. 18031694
3. Lee YJ, Jameson SC, Hogquist KA (2011) Alternative memory in the CD8 T cell lineage. Trends Immunol 32: 50–56. doi: 10.1016/j.it.2010.12.004 21288770
4. Atherly LO, Lucas JA, Felices M, Yin CC, Reiner SL, Berg LJ (2006) The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity 25: 79–91. 16860759
5. Broussard C, Fleischacker C, Horai R, Chetana M, Venegas AM, Sharp LL, et al. (2006) Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 25: 93–104. 16860760
6. Weinreich MA, Odumade OA, Jameson SC, Hogquist KA (2010) T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nat Immunol 11: 709–716. doi: 10.1038/ni.1898 20601952
7. Weinreich MA, Takada K, Skon C, Reiner SL, Jameson SC, Hogquist KA (2009) KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31: 122–130. doi: 10.1016/j.immuni.2009.05.011 19592277
8. Fukuyama T, Kasper LH, Boussouar F, Jeevan T, van Deursen J, Brindle PK (2009) Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development. Mol Cell Biol 29: 3894–3904. doi: 10.1128/MCB.01598-08 19433445
9. Jordan MS, Smith JE, Burns JC, Austin JE, Nichols KE, Aschenbrenner AC, et al. (2008) Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity 28: 359–369. doi: 10.1016/j.immuni.2008.01.010 18342008
10. Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, Pandolfi PP, et al. (2010) Development of promyelocytic zinc finger and ThPOK-expressing innate γδ T cells is controlled by strength of TCR signaling and Id3. J Immunol 184: 1268–1279. doi: 10.4049/jimmunol.0903218 20038637
11. Verykokakis M, Boos MD, Bendelac A, Kee BL (2010) SAP protein-dependent natural killer T-like cells regulate the development of CD8+ T cells with innate lymphocyte characteristics. Immunity 33: 203–215. doi: 10.1016/j.immuni.2010.07.013 20674402
12. Ueda-Hayakawa I, Mahlios J, Zhuang Y (2009) Id3 restricts the developmental potential of γδ lineage during thymopoiesis. J Immunol 182: 5306–5316. doi: 10.4049/jimmunol.0804249 19380777
13. Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, Kee BL (2010) Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent "innate" γδ T cells. PLoS One 5: e9303. doi: 10.1371/journal.pone.0009303 20174563
14. Min HS, Lee YJ, Jeon YK, Kim EJ, Kang BH, Jung KC, et al. (2011) MHC class II-restricted interaction between thymocytes plays an essential role in the production of innate CD8+ T cells. J Immunol 186: 5749–5757. doi: 10.4049/jimmunol.1002825 21478404
15. Lee YJ, Jeon YK, Kang BH, Chung DH, Park CG, Shin HY, et al. (2010) Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans. J Exp Med 207: 237–246. doi: 10.1084/jem.20091519 20038602
16. Treiner E, Lantz O (2006) CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol 18: 519–526. 16870416
17. Virgin HW, Wherry EJ, Ahmed R (2009) Redefining chronic viral infection. Cell 138: 30–50. doi: 10.1016/j.cell.2009.06.036 19596234
18. West EE, Youngblood B, Tan WG, Jin HT, Araki K, Alexe G, et al. (2011) Tight regulation of memory CD8+ T cells limits their effectiveness during sustained high viral load. Immunity 35: 285–298. doi: 10.1016/j.immuni.2011.05.017 21856186
19. Blattman JN, Wherry EJ, Ha SJ, van der Most RG, Ahmed R (2009) Impact of epitope escape on PD–1 expression and CD8 T-cell exhaustion during chronic infection. J Virol 83: 4386–4394. doi: 10.1128/JVI.02524-08 19211743
20. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670–684. 17950003
21. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W (2001) Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med 194: 393–406. 11514597
22. Okazaki T, Honjo T (2006) Rejuvenating exhausted T cells during chronic viral infection. Cell 124: 459–461. 16469690
23. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687. 16382236
24. Park SH, Bae YM, Kim TJ, Ha IS, Kim S, Chi JG, et al. (1992) HLA-DR expression in human fetal thymocytes. Hum Immunol 33: 294–298. 1639632
25. Li W, Kim MG, Gourley TS, McCarthy BP, Sant'Angelo DB, Chang CH (2005) An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 23: 375–386. 16226503
26. Choi EY, Jung KC, Park HJ, Chung DH, Song JS, Yang SD, et al. (2005) Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity 23: 387–396. 16226504
27. Lee YJ, Jung KC, Park SH (2009) MHC class II-dependent T-T interactions create a diverse, functional and immunoregulatory reaction circle. Immunol Cell Biol 87: 65–71. doi: 10.1038/icb.2008.85 19030015
28. Qiao Y, Zhu L, Sofi H, Lapinski PE, Horai R, Mueller K, et al. (2012) Development of promyelocytic leukemia zinc finger-expressing innate CD4 T cells requires stronger T-cell receptor signals than conventional CD4 T cells. Proc Natl Acad Sci U S A 109: 16264–16269. doi: 10.1073/pnas.1207528109 22988097
29. Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, et al. (2010) Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol 185: 4988–4992. doi: 10.4049/jimmunol.1002042 20935204
30. Kaech SM, Cui W (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12: 749–761. doi: 10.1038/nri3307 23080391
31. Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, Barnett BE, et al. (2012) Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338: 1220–1225. doi: 10.1126/science.1229620 23197535
32. Ha SJ, Mueller SN, Wherry EJ, Barber DL, Aubert RD, Sharpe AH, et al. (2008) Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 205: 543–555. doi: 10.1084/jem.20071949 18332181
33. Wijesundara DK, Xi Y, Ranasinghe C (2014) Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design. Front Immunol 5: 412. doi: 10.3389/fimmu.2014.00412 25221557
34. van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, et al. (2014) Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res 111: 53–59. doi: 10.1016/j.antiviral.2014.08.015 25218783
35. Bohne F, Protzer U (2007) Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B. J Viral Hepat 14 Suppl 1: 45–50. 17958642
36. MacDonald HR, Schumann J (2005) The need for natural killer T cells. Nat Med 11: 256–257. 15746936
37. Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat Rev Immunol 7: 505–518. 17589542
38. Nichols KE, Hom J, Gong SY, Ganguly A, Ma CS, Cannons JL, et al. (2005) Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med 11: 340–345. 15711562
39. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, Wei DG, et al. (2007) Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751–762. 18031695
40. Li W, Sofi MH, Rietdijk S, Wang N, Terhorst C, Chang CH (2007) The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction. Immunity 27: 763–774. 18031696
41. Horai R, Mueller KL, Handon RA, Cannons JL, Anderson SM, Kirby MR, et al. (2007) Requirements for selection of conventional and innate T lymphocyte lineages. Immunity 27: 775–785. 18031697
42. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160: 521–540. 6332167
43. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911–4927. 12663797
44. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177–187. 9491999
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2015 Číslo 10
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Chronobiomics: The Biological Clock as a New Principle in Host–Microbial Interactions
- Interferon-γ: The Jekyll and Hyde of Malaria
- Crosslinking of a Peritrophic Matrix Protein Protects Gut Epithelia from Bacterial Exotoxins
- Modulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes